IRIS Accounts Production v25.1.3.33 11569053 Board of Directors Board of Directors 1.4.24 31.3.25 31.3.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh115690532024-03-31115690532025-03-31115690532024-04-012025-03-31115690532023-03-31115690532023-04-012024-03-31115690532024-03-3111569053ns15:EnglandWales2024-04-012025-03-3111569053ns14:PoundSterling2024-04-012025-03-3111569053ns10:Director12024-04-012025-03-3111569053ns10:Director22024-04-012025-03-3111569053ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3111569053ns10:SmallEntities2024-04-012025-03-3111569053ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3111569053ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3111569053ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3111569053ns10:FullAccounts2024-04-012025-03-3111569053ns10:RegisteredOffice2024-04-012025-03-3111569053ns5:CurrentFinancialInstruments2025-03-3111569053ns5:CurrentFinancialInstruments2024-03-3111569053ns5:ShareCapital2025-03-3111569053ns5:ShareCapital2024-03-3111569053ns5:RetainedEarningsAccumulatedLosses2025-03-3111569053ns5:RetainedEarningsAccumulatedLosses2024-03-3111569053ns5:PlantMachinery2024-04-012025-03-3111569053ns5:PlantMachinery2024-03-3111569053ns5:PlantMachinery2025-03-3111569053ns5:PlantMachinery2024-03-3111569053ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3111569053ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3111569053ns10:Director222024-03-3111569053ns10:Director222023-03-3111569053ns10:Director222024-04-012025-03-3111569053ns10:Director222023-04-012024-03-3111569053ns10:Director222025-03-3111569053ns10:Director222024-03-31
REGISTERED NUMBER: 11569053 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2025

for

Griffin Neurosurgery Limited

Griffin Neurosurgery Limited (Registered number: 11569053)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Griffin Neurosurgery Limited

Company Information
for the Year Ended 31 March 2025







DIRECTORS: J R Goodden
Mrs H T Goodden





REGISTERED OFFICE: Suite 12 Jason House
Kerry Hill
Horsforth
Leeds
West Yorkshire
LS18 4JR





REGISTERED NUMBER: 11569053 (England and Wales)





ACCOUNTANTS: Yorkshire Medical Accountants LLP
Suite 12
East Wing, Jason House
Kerry Hill, Horsforth
Leeds
West Yorkshire
LS18 4JR

Griffin Neurosurgery Limited (Registered number: 11569053)

Balance Sheet
31 March 2025

31.3.25 31.3.24
Notes £    £    £   
FIXED ASSETS
Tangible assets 4 17,506 22,711

CURRENT ASSETS
Debtors 5 57,803 114,643
Investments 6 110,804 85,424
Cash at bank and in hand 239,145 167,002
407,752 367,069
CREDITORS
Amounts falling due within one year 7 59,336 84,892
NET CURRENT ASSETS 348,416 282,177
TOTAL ASSETS LESS CURRENT
LIABILITIES

365,922

304,888

PROVISIONS FOR LIABILITIES 4,377 5,678
NET ASSETS 361,545 299,210

CAPITAL AND RESERVES
Called up share capital 104 100
Retained earnings 361,441 299,110
SHAREHOLDERS' FUNDS 361,545 299,210

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Griffin Neurosurgery Limited (Registered number: 11569053)

Balance Sheet - continued
31 March 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 June 2025 and were signed on its behalf by:




J R Goodden - Director



Mrs H T Goodden - Director


Griffin Neurosurgery Limited (Registered number: 11569053)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

Griffin Neurosurgery Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost and 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2024 - 4 ) .

Griffin Neurosurgery Limited (Registered number: 11569053)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2024 100,050
Additions 1,367
At 31 March 2025 101,417
DEPRECIATION
At 1 April 2024 77,339
Charge for year 6,572
At 31 March 2025 83,911
NET BOOK VALUE
At 31 March 2025 17,506
At 31 March 2024 22,711

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade debtors 56,862 113,742
Other debtors 941 901
57,803 114,643

6. CURRENT ASSET INVESTMENTS
31.3.25 31.3.24
£    £   
Listed investments 110,804 85,424

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Bank loans and overdrafts 4,935 9,076
Trade creditors 9 15
Taxation and social security 51,917 61,275
Other creditors 2,475 14,526
59,336 84,892

Griffin Neurosurgery Limited (Registered number: 11569053)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2025 and 31 March 2024:

31.3.25 31.3.24
£    £   
Mrs H T Goodden
Balance outstanding at start of year (6,157 ) 1,241
Amounts advanced 6,002 -
Amounts repaid - (7,398 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (155 ) (6,157 )

Interest is charged on directors' loans at the official rates of interest.

9. RELATED PARTY DISCLOSURES

During the year, total dividends of £18,000 (2024 - £42,000) were paid to the directors .

Included in other creditors at the year end are amounts owing to the directors of £672 (2024 - £12,793).